TargetMol

Ceruletide Ammonium acetate

Product Code:
 
TAR-T14932L
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T14932L-25mg25mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T14932L-50mg50mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T14932L-1mg1mg£272.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T14932L-5mg5mg£482.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T14932L-10mg10mg£667.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Ceruletide Ammonium acetate is a cholecystokinin (CCK) receptor agonist. Ceruletide Ammonium acetate is a safe and effective cholecystokinetic agent and small bowel and exocrine pancreatic stimulant.
CAS:
T14932L
Formula:
C60H77N13O23S2
Molecular Weight:
1412.46
Pathway:
GPCR/G Protein
Purity:
0.98
SMILES:
[H][C@]([C@H](O)C)(C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CC1=CC=CC=C1)=O)CC(O)=O)=O)CCSC)=O)CC2=CNC3=CC=CC=C23)=O)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H]4CCC(N4)=O)=O)CCC(N)=O)=O)CC(O)=O)=O)CC5=CC=C(C=C5)OS(O)(=O)=O)=O.CC(O)=O
Target:
cholecystokinin

References

1. M E Vincent, et al. Pharmacotherapy. Jul-Aug 1982;2(4):223-34.[2] M R Zarrindast, et al. Pharmacol Toxicol. 1995 Dec;77(6):360-4.[3] Joanna Bonior, et al. Int J Mol Sci. 2017 May 2;18(5):929. 2. Smith GP, et al. Ceruletide acts in the abdomen, not in the brain, to produce satiety. Peptides. 1984 Nov-Dec;5(6):1149-57. 3. Mattes JA, et al. Ceruletide for schizophrenia: a double-blind study. Biol Psychiatry. 1985 May;20(5):533-8. doi: 10.1016/0006-3223(85)90024-PMID: 2859054.